Ascentage Pharma Group International (6855.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 16.71B |
| Enterprise Value | 16.22B |
| P/E Ratio | -9.08 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 20.57 |
| Price/Book Ratio | 8.79 |
| Enterprise/Revenue | 19.71 |
| Enterprise/EBITDA | -10.04 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -2.17 |
| Operating Margin | -2.1 |
AD
Management Effectiveness
| Return On Assets | -0.31 |
| Return On Equity | -1.24 |
Income Statement
| Revenue | 559.26M |
| Revenue/Share | 1.53 |
| Gross Profit | 427.35M |
| EBITDA | -1.1B |
| Net Income | -1.21B |
| Diluted EPS | -3.4 |
Balance Sheet
| Total Cash | 2.47B |
| Total Cash/Share | 6.67 |
| Total Debt | 1.98B |
| Total Debt/Equity | 1.49 |
| Current Ratio | 1.79 |
| Book Value Per Share | 3.6 |
Price History
| 52-Week Change | -51.33 |
| 52-Week High | 95.35 |
| 52-Week Low | 30 |
| Moving Average 50 Days | 37.23 |
| Moving Average 200 Days | 51.07 |
Statistics
| Average Volume | 2.57M |
| Shares Outstanding | 372.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
